Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review
S Fathi-Karkan, R Arshad, A Rahdar… - European Journal of …, 2023 - Elsevier
Etoposide (ETO), a popular anticancer drug that inhibits topoisomerase II enzymes, may be
administered more effectively and efficiently due to nanomedicine. The therapeutic …
administered more effectively and efficiently due to nanomedicine. The therapeutic …
Modern developments in the application and function of metal/metal oxide nanocomposite–based antibacterial agents
YF Mustafa - BioNanoScience, 2023 - Springer
Significant health issues have lately been brought on by the dramatic increase in pathogenic
microbes that are resistant to antibiotics. To manage or fight infections brought on by …
microbes that are resistant to antibiotics. To manage or fight infections brought on by …
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
Background The causes for immune-mediated inflammatory diseases (IMIDs) are diverse
and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to …
and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to …
Revolutionizing anticancer drug delivery: Exploring the potential of tamoxifen-loaded nanoformulations
Tamoxifen (TAM), as a hydrophobic drug, is a selective estrogen modulator (SERM) applied
to hormone therapy for breast cancer (BC). Although it is effective and affordable in BC …
to hormone therapy for breast cancer (BC). Although it is effective and affordable in BC …
Novel epirubicin-loaded nanoformulations: advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery
Cancer affects millions of people worldwide, and it is projected that there will be 1,958,310
new cancer cases and 609,820 cancer fatalities in the United States in 2023. Epirubicin …
new cancer cases and 609,820 cancer fatalities in the United States in 2023. Epirubicin …
Research in the field of drug design and development
G Biala, E Kedzierska, M Kruk-Slomka… - Pharmaceuticals, 2023 - mdpi.com
The processes used by academic and industrial scientists to discover new drugs have
recently experienced a true renaissance, with many new and exciting techniques being …
recently experienced a true renaissance, with many new and exciting techniques being …
Recent advancements of aptamers in cancer therapy
S Venkatesan, K Chanda, MM Balamurali - ACS omega, 2023 - ACS Publications
Aptamers are chemical antibodies possessing the capability of overcoming the limitations
posed by conventional antibodies, particularly for diagnostic, therapeutic, and theranostic …
posed by conventional antibodies, particularly for diagnostic, therapeutic, and theranostic …
[HTML][HTML] Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Huntington's disease (HD) is a neurological disorder characterized by a reduction in
medium-spiny neurons in the brain. Currently, there is no cure for HD and treatment relies …
medium-spiny neurons in the brain. Currently, there is no cure for HD and treatment relies …
Development of chitosan-graphene oxide blend nanoparticles for controlled flurbiprofen delivery
The use of natural polymeric nanoparticles (Nps) as drug carriers is a highly promising area
of research in the field of drug delivery systems because of their high efficiency. In this study …
of research in the field of drug delivery systems because of their high efficiency. In this study …
Advanced nanomedicine: redefining therapeutic paradigms for inflammatory bowel disease
Y Zhang, T Wang, M Sun, Y Song… - Advanced …, 2023 - Wiley Online Library
Inflammatory bowel disease (IBD), a chronic and recurrent gastrointestinal inflammatory
disorder with a variety of painful clinical manifestations and an increased risk of …
disorder with a variety of painful clinical manifestations and an increased risk of …